Privacy was defined as a fundamental human right in
the Universal Declaration of Human Rights at the 1948
United Nations General Assembly. However, there is still
no consensus on what constitutes privacy. In this review,
we look at the evolution of privacy as a concept from the
era of Hippocrates to the era of social media and big data.
To appreciate the modern measures of patient privacy
protection and correctly interpret the current regulatory
framework in the United States, we need to analyze and
understand the concepts of individually identifiable
information, individually identifiable health information,
protected health information, and de-identification. The
Privacy Rule of the Health Insurance Portability and
Accountability Act defines the regulatory framework and
casts a balance between protective measures and access
to health information for secondary (scientific) use. The
rule defines the conditions when health information is
protected by law and how protected health information
can be de-identified for secondary use. With the advents
of artificial intelligence and computational linguistics,
computational text de-identification algorithms produce
de-identified results nearly as well as those produced by
human experts, but much faster, more consistently and
basically for free. Modern clinical text de-identification
systems now pave the road to big data and enable
scientists to access de-identified clinical information
while firmly protecting patient privacy. However, clinical
text de-identification is not a perfect process. In order to
maximize the protection of patient privacy and to free
clinical and scientific information from the confines
of electronic healthcare systems, all stakeholders,
including patients, health institutions and institutional
review boards, scientists and the scientific communities,
as well as regulatory and law enforcement agencies must
collaborate closely. On the one hand, public health laws
and privacy regulations define rules and responsibilities
such as requesting and granting only the amount of
health information that is necessary for the scientific
study. On the other hand, developers of de-identification
systems provide guidelines to use different modes of
operations to maximize the effectiveness of their tools
and the success of de-identification. Institutions with
clinical repositories need to follow these rules and
guidelines closely to successfully protect patient privacy.
To open the gates of big data to scientific communities,
healthcare institutions need to be supported in their deidentification
and data sharing efforts by the public,
scientific communities, and local, state, and federal
legislators and government agencies.
Health Insurance Portability and Accountability Act medical informatics confidentiality data anonymization data sharing personally identifiable information privacy
Diğer ID | JA85FR25TS |
---|---|
Bölüm | Araştırma Makalesi |
Yazarlar | |
Yayımlanma Tarihi | 1 Ocak 2018 |
Yayımlandığı Sayı | Yıl 2018 Cilt: 35 Sayı: 1 |